文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

西非三级中心儿童非沙门菌革兰阴性肠杆菌感染趋势

Longitudinal Trends in Pediatric Non-Salmonella Gram-Negative Enterobacterales Infections at a Tertiary Care Center in West Africa, 2005-2023.
PubMed 文献 · J Infect Dis · 2026-01-01

该研究回顾分析马里巴马科Gabriel Touré医院2005–2023年0–15岁病原阳性患儿,描述非沙门菌革兰阴性肠杆菌(GNE)负担与耐药变迁。病原阳性者中非沙门菌GNE比例从6%升至38%,三代头孢耐药与多重耐药均升至93%。部分年龄和来源患儿感染非沙门菌GNE的住院死亡 odds 更高。

要点

  • 病原阳性患儿中非沙门菌GNE占比由6%升至38%。
  • 2005–2009至2021–2023,三代头孢耐药与多重耐药均由30%、55%升至93%。
  • 0–2月龄院外及3月–15岁院内外患儿感染非沙门菌GNE死亡 odds 更高。

核心结论

  • 马里大型儿科转诊中心数据显示,多重耐药革兰阴性肠杆菌负担高且持续上升。

研究设计与样本

  • 回顾性分析2005–2023年巴马科Gabriel Touré医院0–15岁病原阳性患儿,共3803例,其中392例至少分离出1株非沙门菌GNE。
  • 2021–2023年分离株行全基因组测序以识别耐药基因。

主要发现

  • 病原阳性患者中非沙门菌GNE比例从2005–2023年的6%升至38%。
  • 非沙门菌GNE三代头孢耐药与多重耐药从2005–2009年的30%和55%升至2021–2023年的93%(两者均为93%)。
  • 0–2月龄院外患儿、3月–15岁院内及院外患儿感染非沙门菌GNE的死亡 odds 分别为3.17(95% CI 1.69–5.95)、2.13(95% CI 1.44–3.14)、2.25(95% CI 1.38–3.66)。
  • 测序确认出现新兴病原体Pantoea dispersa,并发现多重耐药基因。

临床怎么用

  • 在类似资源有限地区,应加强抗菌药物可及性、诊断能力与抗菌药物管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite data demonstrating the high prevalence of third-generation cephalosporin resistant Gram-negative Enterobacterales (GNE) among children in sub-Saharan Africa, longitudinal descriptions of resistance among these pathogens from Francophone West Africa remain rare. METHODS: We conducted a retrospective analysis of pathogen-positive children 0-15 years old included in an invasive bacterial infection study at l'Hôpital Gabriel Touré (in Bamako, Mali) from 2005 to 2023. We aimed to describe changes in pathogen burden and non-Salmonella GNE resistance over time and compare in-hospital mortality between patients with and without non-Salmonella GNE pathogens. Isolates from 2021 to 2023 underwent whole-genome sequencing to identify genes conferring antimicrobial resistance. RESULTS: Of 3803 pathogen-positive patients, 392 grew at least 1 non-Salmonella GNE pathogen. The proportion of pathogen-positive patients with non-Salmonella GNE increased (6% vs 38%) from 2005-2023. Third-generation cephalosporin and multidrug resistance among non-Salmonella GNE increased from 30% and 55%, respectively, in 2005-2009, to 93% (both) by 2021-2023. Children 0-2 months old from outside Bamako and 3 months-15 years old from and from outside Bamako with non-Salmonella GNE had higher mortality odds (3.17, 95% CI 1.69-5.95; 2.13, 95% CI 1.44-3.14; and 2.25, 95% CI 1.38-3.66, respectively) than similar patients with other pathogens. Sequencing confirmed the presence of the emerging pathogen Pantoea dispersa and revealed genes conferring multidrug resistance. CONCLUSIONS: Data from this large pediatric referral center in Mali show a high and rising burden of multidrug-resistant Gram-negative Enterobacterales. These patterns reflect concerns increasingly reported across sub-Saharan Africa, highlighting the urgency of strengthening antimicrobial access, diagnostics, and stewardship strategies in similar settings.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Cherukumilli S, Keita AM, Still W, et al. Longitudinal Trends in Pediatric Non-Salmonella Gram-Negative Enterobacterales Infections at a Tertiary Care Center in West Africa, 2005-2023. J Infect Dis. 2026. PMID: 41525800. doi:10.1093/infdis/jiag027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。